LINC00964: A Long Intergenic Non-Protein Coding RNA as a Drug Target or Biomarker

Target Name: LINC00964

NCBI ID: G157381

LINC00964

Other Name(s): long intergenic non-protein coding RNA 964 | Long intergenic non-protein coding RNA 964

LINC00964: A Long Intergenic Non-Protein Coding RNA as a Drug Target or Biomarker

LINC00964 is a long intergenic non-protein coding RNA (lncRNA) that has been identified as a potential drug target or biomarker. It is a non-coding RNA molecule that is expressed in a variety of tissues and cells, including the brain, heart, and gastrointestinal tract. The function of LINC00964 is not well understood, but its potential involvement in various biological processes makes it an attractive target for research and development of new treatments.

Drug Target Potential

LINC00964 has been shown to play a role in several cellular processes that are associated with various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its expression has been associated with the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key features of LINC00964 is its ability to interact with protein targets. This interaction suggests that LINC00964 may be a potential drug target for the treatment of diseases that are characterized by the over-expression or under-expression of protein targets.

Biomarker Potential

LINC00964 has also been shown to be involved in the regulation of various biological processes that are associated with the development and progression of diseases. This suggests that it may be a potential biomarker for the diagnosis and treatment of diseases.

Expression and Regulation

LINC00964 is a long non-coding RNA molecule that is expressed in a variety of tissues and cells. It is expressed in the brain, heart, and gastrointestinal tract, and has been shown to be involved in the regulation of various cellular processes, including cell adhesion, migration, and survival.

The expression of LINC00964 is regulated by several factors, including the levels of various RNA molecules, such as miRNA and miRNA-like particles. These molecules are known to interact with LINC00964 and regulate its expression levels.

Function and Interaction

The function of LINC00964 is not well understood, but its potential involvement in various biological processes makes it an attractive target for research and development of new treatments. Its interaction with protein targets suggests that it may be a potential drug target for the treatment of diseases that are characterized by the over-expression or under-expression of protein targets.

Conclusion

LINC00964 is a long intergenic non-protein coding RNA that has been identified as a potential drug target or biomarker. Its expression is regulated by several factors, including the levels of various RNA molecules, and its interaction with protein targets suggests that it may be a potential target for the treatment of diseases that are characterized by the over-expression or under-expression of protein targets. Further research is needed to fully understand the function of LINC00964 and its potential as a drug target or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 964

The "LINC00964 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00964 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets